Home › Funds › Catalio Capital Management, LP › COGT
Catalio Capital Management, LP position in COGT
COGENT BIOSCIENCES INC · Health Care
Catalio Capital Management, LP reported holding 167,716 shares of COGT (COGENT BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$5.4M, representing 1.00% of its reported portfolio and ranking #31 among its reported holdings. Catalio Capital Management, LP first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Catalio Capital Management, LP's COGT position evolved
Catalio Capital Management, LP first disclosed a stake in COGT in Q3 2026 at 167,716 shares (US$5.4M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 167.72K | $5.37M | New |
About COGT and 13F data
COGT (COGENT BIOSCIENCES INC) is a Health Care company. 51 other funds we track also report a position in COGT — the largest reported positions include DEERFIELD MANAGEMENT COMPANY, L.P. (US$190.7M), Fairmount Funds Management LLC (US$176.2M), Kynam Capital Management, LP (US$121.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding COGT
- DEERFIELD MANAGEMENT COMPANY, L.P. 5.96M sh · $190.74M · Q3 2026
- Fairmount Funds Management LLC 5.50M sh · $176.22M · Q3 2026
- Kynam Capital Management, LP 3.79M sh · $121.43M · Q3 2026
- TCG Crossover Management, LLC 2.50M sh · $80.05M · Q3 2026
- Deep Track Capital, LP 2.50M sh · $80.05M · Q3 2026
- Octagon Capital Advisors LP 2.35M sh · $75.25M · Q3 2026
- RTW INVESTMENTS, LP 2.31M sh · $73.93M · Q3 2026
- ORBIMED ADVISORS LLC 2.00M sh · $64.16M · Q3 2026
- Venrock Adviser, LLC 1.64M sh · $52.58M · Q3 2026
- EMERALD ADVISERS, LLC 1.61M sh · $51.67M · Q3 2026
- Siren, L.L.C. 1.61M sh · $51.53M · Q3 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 1.57M sh · $50.42M · Q3 2026
More on Catalio Capital Management, LP
FAQ
How long has Catalio Capital Management, LP held COGT?
Catalio Capital Management, LP has disclosed COGT holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Catalio Capital Management, LP's current position in COGT?
As of Q3 2026, Catalio Capital Management, LP holds 167.72K shares of COGT (COGENT BIOSCIENCES INC), valued at $5.37M, representing 1.00% of its reported portfolio and ranking #31.
Has Catalio Capital Management, LP been buying or selling COGT?
In the latest 13F filing (Q3 2026), Catalio Capital Management, LP newly opened its position in COGT.
Which other funds hold COGT?
Other major institutional holders of COGT include DEERFIELD MANAGEMENT COMPANY, L.P., Fairmount Funds Management LLC, Kynam Capital Management, LP, among 51 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.